News of Note—Altimmune’s new CEO, Scripps’ HIV vaccine and more

newspaper
(Pixabay)

Here is some other vaccine news of note for the week:

> Altimmune has poached Neos Therapeutics’ CEO, Vipin Crag, Ph.D., to succeed Bill Enright as its president and CEO. Release

> Scripps Research scientists have found a way to stabilize HIV envelope protein for a new HIV vaccine. The candidate elicited robust anti-HIV antibody responses in mice and rabbits, the team reported. Release

Watch the Free Webinar

Chemistry Through Biology: Translating Molecular Biology Technologies into Practical Processes for API Production

Learn about the key advances and critical hurdles in transforming emerging molecular biology technologies into practical applications with commercially viable processes.

> The NIH awarded Tulane University School of Medicine a contract worth up to $8.5 million to develop a more effective and longer-lasting vaccine against whooping cough. Release

Suggested Articles

Amid the COVID-19 pandemic, many teams of researchers are working on potential vaccines. We asked experts to assess progress—and point out challenges.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Pfizer posted positive top-line results for a trial of its 20-valent pneumococcal vaccine, potentially setting up a filing by the end of 2020.